Search
- Oct 3, 2023
Michal Preminger talks about J&J's collaboration through science in Kendall Square and beyond
The head of JNJ Innovation for the east of North America talks about recent deals and JNJ’s support of science at its earliest stages.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A